Bax inhibitor peptide V5
CAS No. 579492-81-2
Bax inhibitor peptide V5 ( Val-Pro-Met-Leu-Lys;BIP-V5 )
Catalog No. M15125 CAS No. 579492-81-2
A cell-permeable synthetic peptide inhibitor of Bax conformational change and mitochondrial translocation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 78 | Get Quote |
|
10MG | 113 | Get Quote |
|
25MG | 240 | Get Quote |
|
50MG | 399 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBax inhibitor peptide V5
-
NoteResearch use only, not for human use.
-
Brief DescriptionA cell-permeable synthetic peptide inhibitor of Bax conformational change and mitochondrial translocation.
-
DescriptionA cell-permeable synthetic peptide inhibitor of Bax conformational change and mitochondrial translocation; inhibits Bax-mediated apoptosis in vitro; inhibit anti-cancer drug-induced apoptosis in vitro; upregulats expression of anti-apoptotic proteins Bcl-2 and XIAP by more than 3- and 11-fold and downregulates expression of apoptosis-inducing proteins Bax, Bad, and nuclear factor-kappaB-p65 by 10, 30, and nearly 50%, respectively, on pancreatic islets in a mouse model.
-
SynonymsVal-Pro-Met-Leu-Lys;BIP-V5
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number579492-81-2
-
Formula Weight586.79
-
Molecular FormulaC27H50N6O6S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 30 mg/mL
-
SMILESCC(C)CC(C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCSC)NC(=O)C1CCCN1C(=O)C(C(C)C)N
-
Chemical NameL-Lysine, L-valyl-L-prolyl-L-methionyl-L-leucyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sawatzky DA, et al. Am J Pathol. 2006 Jan;168(1):33-41.
2. Rivas-Carrillo JD, et al. Diabetes. 2007 May;56(5):1259-67.
3. Yoshida T, et al. Biochem Biophys Res Commun. 2004 Sep 3;321(4):961-6.
2. Rivas-Carrillo JD, et al. Diabetes. 2007 May;56(5):1259-67.
3. Yoshida T, et al. Biochem Biophys Res Commun. 2004 Sep 3;321(4):961-6.
molnova catalog
related products
-
Mcl-1-Puma inhibitor...
Mcl-1-Puma inhibitor 8 is a small-molecule dual-acting compound that targets the apoptotic Mcl-1-PUMA interface with Ki of 0.3 uM (Mcl-1, FPA).
-
BAM7
BAM 7 is a direct and selective activator of proapoptotic Bax with EC50 of 3.3 μM.
-
HA14-1
HA14-1 a small molecule, nonpeptidic Bcl-2 antagonist that binds Bcl-2 surface pocket with binding IC50 of 9 uM.